Skip to main content

Table 1 PC patients of the validation cohort matched by Gleason score with patients of the PCTA collection

From: Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us